MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 15 | 0.0 |
Blotting, Western | 6 | 0.0 |
Cell Line | 9 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
Humans | 99 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Molecular Sequence Data | 29 | 0.0 |
Phosphorylation | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 85 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Time Factors | 4 | 0.0 |
Up-Regulation | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
DNA-Binding Proteins/biosynthesis/genetics | 2 | 2.0 |
Gene Expression Regulation, Developmental | 13 | 1.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Kidney/*embryology | 5 | 17.0 |
Membrane Proteins/biosynthesis/genetics | 2 | 5.0 |
Mesoderm/metabolism | 2 | 2.0 |
Nephroblastoma/*genetics | 3 | 2.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 31 | 0.0 |
Animals | 68 | 0.0 |
Base Sequence | 21 | 0.0 |
Cell Differentiation/*physiology | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 9 | 1.0 |
3T3 Cells | 2 | 0.0 |
Carrier Proteins/*chemistry/metabolism | 2 | 5.0 |
Mice | 44 | 0.0 |
Models, Biological | 4 | 0.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Transfection | 9 | 0.0 |
Aged | 6 | 0.0 |
Female | 45 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Male | 39 | 0.0 |
Middle Aged | 11 | 0.0 |
Phenotype | 17 | 0.0 |
Cell Division | 7 | 0.0 |
Immunohistochemistry | 8 | 0.0 |
In Situ Hybridization | 13 | 0.0 |
Mice, Knockout | 6 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Transcription, Genetic | 8 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 9 | 2.0 |
*Gene Expression Regulation, Developmental | 11 | 1.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Homeodomain Proteins/metabolism | 3 | 3.0 |
Mesencephalon/*embryology/physiology | 2 | 100.0 |
Mice, Transgenic | 3 | 0.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
Transcription Factors/*genetics/metabolism | 9 | 2.0 |
Chick Embryo | 5 | 0.0 |
Cloning, Molecular | 10 | 0.0 |
Drosophila/genetics | 3 | 2.0 |
*Drosophila Proteins | 4 | 0.0 |
Homeodomain Proteins/genetics/metabolism | 3 | 4.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Mice, Mutant Strains | 8 | 1.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 7 | 0.0 |
Kidney/abnormalities/*embryology/metabolism | 2 | 100.0 |
Kidney, Cystic/genetics | 2 | 40.0 |
Mutation/genetics | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Zebrafish/*embryology/genetics | 2 | 18.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Fetus | 5 | 0.0 |
*Nuclear Proteins | 9 | 0.0 |
Proto-Oncogene Proteins/genetics/metabolism | 3 | 1.0 |
*Zebrafish Proteins | 3 | 1.0 |
DNA-Binding Proteins/*metabolism | 7 | 0.0 |
Genes, Reporter | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Transcription Factors/*metabolism | 8 | 0.0 |
DNA-Binding Proteins/genetics | 8 | 0.0 |
Embryo, Nonmammalian | 2 | 5.0 |
Homeodomain Proteins/genetics | 5 | 2.0 |
Mesencephalon/*embryology | 2 | 18.0 |
Mutation | 15 | 0.0 |
Nerve Tissue Proteins/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Rhombencephalon/*embryology | 2 | 33.0 |
Trans-Activators/genetics | 5 | 2.0 |
Adult | 15 | 0.0 |
Cell Differentiation | 6 | 0.0 |
Cell Lineage | 2 | 0.0 |
Child, Preschool | 10 | 0.0 |
Gestational Age | 3 | 0.0 |
Infant | 8 | 0.0 |
Pedigree | 13 | 0.0 |
Pregnancy | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 24 | 1.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Transcription Factors/*genetics | 28 | 1.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Abnormalities, Multiple/*genetics | 8 | 2.0 |
DNA Mutational Analysis | 6 | 0.0 |
Exons/genetics | 4 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Cells, Cultured | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 6 | 0.0 |
Transcription Factors/metabolism | 6 | 0.0 |
Multigene Family | 2 | 0.0 |
Adolescent | 8 | 0.0 |
Child | 13 | 0.0 |
Heterozygote | 7 | 0.0 |
Kidney/*abnormalities/metabolism/pathology | 2 | 100.0 |
Optic Nerve/abnormalities | 3 | 60.0 |
Gene Expression Regulation, Developmental/*physiology | 3 | 2.0 |
Chromosome Mapping | 8 | 0.0 |
*Chromosomes, Human, Pair 10 | 4 | 2.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Kidney/abnormalities | 2 | 10.0 |
DNA Primers | 4 | 0.0 |
Gene Expression | 5 | 0.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Kidney Diseases/*genetics/pathology | 2 | 28.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Syndrome | 13 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 4 | 0.0 |
Embryonic and Fetal Development/genetics | 3 | 3.0 |
Genes, Wilms Tumor | 2 | 3.0 |
*Nerve Growth Factors | 2 | 1.0 |
Nerve Tissue Proteins/genetics/metabolism | 2 | 2.0 |
Receptor Protein-Tyrosine Kinases/genetics/metabolism | 2 | 3.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Transcription Factors/physiology | 2 | 0.0 |
WT1 Proteins | 6 | 2.0 |
*Apoptosis | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Dogs | 2 | 0.0 |
Homozygote | 3 | 0.0 |
In Situ Nick-End Labeling | 3 | 0.0 |
Proliferating Cell Nuclear Antigen/metabolism | 2 | 0.0 |
Exons | 5 | 0.0 |
Lod Score | 2 | 0.0 |
Models, Genetic | 3 | 0.0 |
Binding Sites | 4 | 0.0 |
Conserved Sequence | 4 | 0.0 |
Gene Library | 3 | 0.0 |
Plasmids | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Apoptosis | 4 | 0.0 |
*Gene Expression | 3 | 0.0 |
Transcription Factors/genetics | 5 | 0.0 |
Morphogenesis | 2 | 0.0 |
Trans-Activators/metabolism | 4 | 0.0 |
*Genes, Homeobox | 3 | 1.0 |
Homeodomain Proteins/*genetics | 2 | 0.0 |
beta-Galactosidase/metabolism | 2 | 1.0 |
Point Mutation | 2 | 0.0 |
Alleles | 3 | 0.0 |
Chromosomes, Human, Pair 10 | 3 | 2.0 |
Coloboma/*genetics | 6 | 46.0 |
Haplotypes | 2 | 0.0 |
Infant, Newborn | 5 | 0.0 |
Kidney/*abnormalities | 4 | 16.0 |
Linkage Disequilibrium | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Apoptosis/genetics | 3 | 1.0 |
Gene Silencing | 2 | 0.0 |
*Mutation | 6 | 0.0 |
Cell Division/physiology | 3 | 0.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Kidney Diseases/*genetics | 2 | 5.0 |
Coloboma/genetics | 2 | 40.0 |
Kidney Neoplasms/*genetics/metabolism | 2 | 7.0 |
DNA Primers/genetics | 2 | 0.0 |
Genes, Dominant | 4 | 0.0 |
Eye Abnormalities/*genetics | 2 | 5.0 |
Eye Proteins/*genetics | 2 | 1.0 |
Blotting, Northern | 3 | 0.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Glomerulosclerosis, Focal/*metabolism/pathology | 2 | 66.0 |
Phylogeny | 2 | 0.0 |
Transcription Factors/*biosynthesis/genetics | 2 | 2.0 |
Eye Proteins/*genetics/metabolism | 2 | 7.0 |
*Homeodomain Proteins | 3 | 1.0 |
Vesico-Ureteral Reflux/*genetics | 4 | 57.0 |
Kidney/metabolism | 2 | 0.0 |
Embryonic and Fetal Development/*genetics | 2 | 2.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
Gene Expression/*physiology | 3 | 3.0 |
*Frameshift Mutation | 2 | 1.0 |
Kidney | 2 | 0.0 |
Trans-Activators/*genetics | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Dinucleotide Repeats | 2 | 2.0 |
Genetic Markers | 2 | 0.0 |
Sequence Tagged Sites | 2 | 0.0 |
DNA Footprinting | 2 | 0.0 |
Deoxyribonuclease I/metabolism | 2 | 1.0 |
*Genes, Wilms Tumor | 5 | 2.0 |
Protein p53/genetics | 2 | 1.0 |
Trans-Activation (Genetics) | 5 | 0.0 |
Pseudohermaphroditism/*genetics | 2 | 14.0 |
Optic Nerve/*abnormalities | 4 | 50.0 |
Body Patterning | 2 | 3.0 |
Kidney Neoplasms/*metabolism/pathology | 2 | 6.0 |
Nephroblastoma/*metabolism/pathology | 2 | 40.0 |
Reference Values | 3 | 0.0 |
Fibroblast Growth Factors/metabolism | 2 | 3.0 |
WT1 Proteins/*genetics/metabolism | 2 | 22.0 |
Apoptosis/*physiology | 2 | 0.0 |
Transcription Factors/genetics/*physiology | 2 | 1.0 |
Biological Markers | 2 | 0.0 |
English Abstract | 3 | 0.0 |
Microfilament Proteins/metabolism | 2 | 2.0 |
WT1 Proteins/metabolism | 2 | 25.0 |
Nerve Tissue Proteins/metabolism | 2 | 0.0 |
Biopsy | 2 | 0.0 |
